NLRP7 and related inflammasome activating pattern recognition receptors and their function in host defense and disease

Microbes and Infection

Volumn 15, Issue 8-9, 2013, Pages 630-639

  Radian, Alexander D ^a   de Almeida, Lucia ^a   Dorfleutner, Andrea ^a   Stehlik, Christian ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

AIM2 like receptor; Hydatidiform mole; Inflammasome; Inflammation; Nod like receptor; Pattern recognition receptor

Indexed keywords

AIM 2 PROTEIN; CASPASE 11; CASPASE 4; CASPASE 5; CASPASE 8; FIBROBLAST GROWTH FACTOR 2; HIGH MOBILITY GROUP B1 PROTEIN; IFII 6 PROTEIN; INFLAMMASOME; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; NLRC 4 PROTEIN; NLRC 5 PROTEIN; NLRP 1 PROTEIN; NLRP 3 PROTEIN; NLRP 6 PROTEIN; NLRP 7 PROTEIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; PEPTIDES AND PROTEINS; PYRIN PROTEIN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ARTHROPATHY; AUTOINFLAMMATORY DISEASE; CELL ACTIVATION; CELL DEATH; CINCA SYNDROME; DNA BINDING; FAMILIAL MEDITERRANEAN FEVER; GENE MUTATION; HOST RESISTANCE; HUMAN; METABOLIC DISORDER; MUCKLE WELLS SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84880600772     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2013.04.001     Document Type: Short Survey

References (80)

1. Martinon F., Burns K., Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-1beta. Mol. Cell 2002, 10:417-426.
2. Keller M., Ruegg A., Werner S., Beer H.D. Active caspase-1 is a regulator of unconventional protein secretion. Cell 2008, 132:818-831.
3. Rathinam V.A.K., Vanaja S.K., Waggoner L., Sokolovska A., Becker C., Stuart L.M., Leong J.M., Fitzgerald K.A. TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria. Cell 2012, 150:606-619.
4. Gringhuis S.I., Kaptein T.M., Wevers B.A., Theelen B., van der Vlist M., Boekhout T., Geijtenbeek T.B.H. Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1β via a noncanonical caspase-8 inflammasome. Nat. Immunol. 2012, 13:246-254.
5. Pierini R., Juruj C., Perret M., Jones C.L., Mangeot P., Weiss D.S., Henry T. AIM2/ASC triggers caspase-8-dependent apoptosis in Francisella-infected caspase-1-deficient macrophages. Cell. Death Differ. 2012, 19:1709-1721.
6. Fink S.L., Cookson B.T. Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell. Microbiol. 2006, 8:1812-1825.
7. Srinivasula S.M., Poyet J.-L., Razmara M., Datta P., Zhang Z., Alnemri E.S. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J. Biol. Chem. 2002, 277:21119-21122.
8. Stehlik C., Lee S.H., Dorfleutner A., Stassinopoulos A., Sagara J., Reed J.C. Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation. J. Immunol. 2003, 171:6154-6163.
9. Franchi L., Amer A., Body-Malapel M., Kanneganti T.D., Ozoren N., Jagirdar R., Inohara N., Vandenabeele P., Bertin J., Coyle A., Grant E.P., Nunez G. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin-1beta in Salmonella-infected macrophages. Nat. Immunol. 2006, 7:576-582.
10. Mariathasan S., Newton K., Monack D.M., Vucic D., French D.M., Lee W.P., Roose-Girma M., Erickson S., Dixit V.M. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004, 430:213-218.
11. Miao E.A., Alpuche-Aranda C.M., Dors M., Clark A.E., Bader M.W., Miller S.I., Aderem A. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin-1beta via Ipaf. Nat. Immunol. 2006, 7:569-575.
12. Bryan N.B., Dorfleutner A., Rojanasakul Y., Stehlik C. Activation of inflammasomes requires intracellular redistribution of the apoptotic speck-like protein containing a caspase recruitment domain. J. Immunol. 2009, 182:3173-3182.
13. Broz P., von Moltke J., Jones J.W., Vance R.E., Monack D.M. Differential requirement for caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing. Cell Host Microbe 2010, 8:471-483.
14. Boyden E.D., Dietrich W.F. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat. Genet. 2006, 38:240-244.
15. Faustin B., Lartigue L., Bruey J.M., Luciano F., Sergienko E., Bailly-Maitre B., Volkmann N., Hanein D., Rouiller I., Reed J.C. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol. Cell 2007, 25:713-724.
16. Kovarova M., Hesker P.R., Jania L., Nguyen M., Snouwaert J.N., Xiang Z., Lommatzsch S.E., Huang M.T., Ting J.P.-Y., Koller B.H. NLRP1-dependent pyroptosis leads to acute lung injury and morbidity in mice. J. Immunol. 2012, 189:2006-2016.
17. Lee G.-S., Subramanian N., Kim A.I., Aksentijevich I., Goldbach-Mansky R., Sacks D.B., Germain R.N., Kastner D.L., Chae J.J. The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature 2012, 492:123-127.
18. Murakami T., Ockinger J., Yu J., Byles V., McColl A., Hofer A.M., Horng T. Critical role for calcium mobilization in activation of the NLRP3 inflammasome. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:11282-11287.
19. Shimada K., Crother T.R., Karlin J., Dagvadorj J., Chiba N., Chen S., Ramanujan V.K., Wolf A.J., Vergnes L., Ojcius D.M., Rentsendorj A., Vargas M., Guerrero C., Wang Y., Fitzgerald K.A., Underhill D.M., Town T., Arditi M. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 2012, 36:401-414.
20. Shenoy A.R., Wellington D.A., Kumar P., Kassa H., Booth C.J., Cresswell P., MacMicking J.D. GBP5 promotes NLRP3 inflammasome assembly and immunity in mammals. Science 2012, 336:481-485.
21. Hoffman H.M., Scott P., Mueller J.L., Misaghi A., Stevens S., Yancopoulos G.D., Murphy A., Valenzuela D.M., Liu-Bryan R. Role of the leucine-rich repeat domain of cryopyrin/NALP3 in monosodium urate crystal-induced inflammation in mice. Arthritis Rheum. 2010, 62:2170-2179.
22. Grenier J.M., Wang L., Manji G.A., Huang W.J., Al-Garawi A., Kelly R., Carlson A., Merriam S., Lora J.M., Briskin M., DiStefano P.S., Bertin J. Functional screening of five PYPAF family members identifies PYPAF5 as a novel regulator of NF-kappaB and caspase-1. FEBS. Lett. 2002, 530:73-78.
23. Elinav E., Strowig T., Kau A.L., Henao-Mejia J., Thaiss C.A., Booth C.J., Peaper D.R., Bertin J., Eisenbarth S.C., Gordon J.I., Flavell R.A. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011, 145:745-757.
24. Anand P.K., Malireddi R.K.S., Lukens J.R., Vogel P., Bertin J., Lamkanfi M., Kanneganti T.-D. NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens. Nature 2012, 488:389-393.
25. Miao E.A., Mao D.P., Yudkovsky N., Bonneau R., Lorang C.G., Warren S.E., Leaf I.A., Aderem A. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:3076-3080.
26. Qu Y., Misaghi S., Izrael-Tomasevic A., Newton K., Gilmour L.L., Lamkanfi M., Louie S., Kayagaki N., Liu J., Kömüves L., Cupp J.E., Arnott D., Monack D., Dixit V.M. Phosphorylation of NLRC4 is critical for inflammasome activation. Nature 2012, 490:539-542.
27. Kofoed E.M., Vance R.E. NAIPs: building an innate immune barrier against bacterial pathogens. NAIPs function as sensors that initiate innate immunity by detection of bacterial proteins in the host cell cytosol. Bioessays 2012, 34:589-598.
28. Meissner T.B., Li A., Kobayashi K.S. NLRC5: a newly discovered MHC class I transactivator (CITA). Microbe. Infect. 2011, 14:477-484.
29. Meissner T.B., Li A., Biswas A., Lee K.H., Liu Y.J., Bayir E., Iliopoulos D., van den Elsen P.J., Kobayashi K.S. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:13794-13799.
30. Davis B.K., Roberts R.A., Huang M.T., Willingham S.B., Conti B.J., Brickey W.J., Barker B.R., Kwan M., Taxman D.J., Accavitti-Loper M.A., Duncan J.A., Ting J.P. Cutting edge: NLRC5-dependent activation of the inflammasome. J. Immunol. 2011, 186:1333-1337.
31. Kumar H., Pandey S., Zou J., Kumagai Y., Takahashi K., Akira S., Kawai T. NLRC5 deficiency does not influence cytokine induction by virus and bacteria infections. J. Immunol. 2010, 186:994-1000.
32. Cridland J.A., Curley E.Z., Wykes M.N., Schroder K., Sweet M.J., Roberts T.L., Ragan M.A., Kassahn K.S., Stacey K.J. The mammalian PYHIN gene family: phylogeny, evolution and expression. BMC Evol. Biol. 2012, 12:140.
33. Albrecht M., Choubey D., Lengauer T. The HIN domain of IFI-200 proteins consists of two OB folds. Biochem. Biophys. Res. Commun. 2005, 327:679-687.
34. Fernandes-Alnemri T., Yu J.W., Juliana C., Solorzano L., Kang S., Wu J., Datta P., McCormick M., Huang L., McDermott E., Eisenlohr L., Landel C.P., Alnemri E.S. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat. Immunol. 2010, 11:385-393.
35. Rathinam V.A., Jiang Z., Waggoner S.N., Sharma S., Cole L.E., Waggoner L., Vanaja S.K., Monks B.G., Ganesan S., Latz E., Hornung V., Vogel S.N., Szomolanyi-Tsuda E., Fitzgerald K.A. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat. Immunol. 2010, 11:395-402.
36. Roberts T.L., Idris A., Dunn J.A., Kelly G.M., Burnton C.M., Hodgson S., Hardy L.L., Garceau V., Sweet M.J., Ross I.L., Hume D.A., Stacey K.J. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 2009, 323:1057-1060.
37. Kerur N., Veettil M.V., Sharma-Walia N., Bottero V., Sadagopan S., Otageri P., Chandran B. IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi sarcoma-associated herpesvirus infection. Cell Host Microbe 2011, 9:363-375.
38. Chae J.J., Wood G., Masters S.L., Richard K., Park G., Smith B.J., Kastner D.L. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:9982-9987.
39. Papin S., Cuenin S., Agostini L., Martinon F., Werner S., Beer H.D., Grutter C., Grutter M., Tschopp J. The SPRY domain of pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell. Death Differ. 2007, 14:1457-1466.
40. Shoham N.G., Centola M., Mansfield E., Hull K.M., Wood G., Wise C.A., Kastner D.L. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:13501-13506.
41. Yu J.W., Fernandes-Alnemri T., Datta P., Wu J., Juliana C., Solorzano L., McCormick M., Zhang Z., Alnemri E.S. Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants. Mol. Cell 2007, 28:214-227.
42. Chae J.J., Cho Y.H., Lee G.S., Cheng J., Liu P.P., Feigenbaum L., Katz S.I., Kastner D.L. Gain-of-function pyrin mutations induce NLRP3 protein-independent interleukin-1beta activation and severe autoinflammation in mice. Immunity 2011, 34:755-768.
43. Messaed C., Akoury E., Djuric U., Zeng J., Saleh M., Gilbert L., Seoud M., Qureshi S., Slim R. NLRP7, a nucleotide oligomerization domain-like receptor protein, is required for normal cytokine secretion and co-localizes with golgi and the microtubule-organizing center. J. Biol. Chem. 2011, 286:43313-43323.
44. Kinoshita T., Wang Y., Hasegawa M., Imamura R., Suda T. PYPAF3, a PYRIN-containing APAF-1-like protein, is a feedback regulator of caspase-1-dependent interleukin-1beta secretion. J. Biol. Chem. 2005, 280:21720-21725.
45. Khare S., Dorfleutner A., Bryan N.B., Yun C., Radian A.D., de Almeida L., Rojanasakul Y., Stehlik C. An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages. Immunity 2012, 36:464-476.
46. Kinoshita T., Kondoh C., Hasegawa M., Imamura R., Suda T. Fas-associated factor 1 is a negative regulator of PYRIN-containing Apaf-1-like protein 1. Int. Immunol. 2006, 18:1701-1706.
47. Pinheiro A.S., Proell M., Eibl C., Page R., Schwarzenbacher R., Peti W. Three-dimensional structure of the NLRP7 pyrin domain: insight into pyrin-pyrin-mediated effector domain signaling in innate immunity. J. Biol. Chem. 2010, 285:27402-27410.
48. Masters S.L., Simon A., Aksentijevich I., Kastner D.L. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu. Rev. Immunol. 2009, 27:621-668.
49. Aksentijevich I., C D.P., Remmers E.F., Mueller J.L., Le J., Kolodner R.D., Moak Z., Chuang M., Austin F., Goldbach-Mansky R., Hoffman H.M., Kastner D.L. The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum. 2007, 56:1273-1285.
50. Meng G., Zhang F., Fuss I., Kitani A., Strober W. A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity 2009, 30:860-874.
51. Brydges S.D., Mueller J.L., McGeough M.D., Pena C.A., Misaghi A., Gandhi C., Putnam C.D., Boyle D.L., Firestein G.S., Horner A.A., Soroosh P., Watford W.T., O'Shea J.J., Kastner D.L., Hoffman H.M. Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity. Immunity 2009, 30:875-887.
52. Martinon F., Petrilli V., Mayor A., Tardivel A., Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, 440:237-241.
53. Dostert C., Petrilli V., Van Bruggen R., Steele C., Mossman B.T., Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320:674-677.
54. Hornung V., Bauernfeind F., Halle A., Samstad E.O., Kono H., Rock K.L., Fitzgerald K.A., Latz E. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 2008, 9:847-856.
55. Cassel S.L., Eisenbarth S.C., Iyer S.S., Sadler J.J., Colegio O.R., Tephly L.A., Carter A.B., Rothman P.B., Flavell R.A., Sutterwala F.S. The Nalp3 inflammasome is essential for the development of silicosis. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:9035-9040.
56. Halle A., Hornung V., Petzold G.C., Stewart C.R., Monks B.G., Reinheckel T., Fitzgerald K.A., Latz E., Moore K.J., Golenbock D.T. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 2008, 9:857-865.
57. Masters S.L., Dunne A., Subramanian S.L., Hull R.L., Tannahill G.M., Sharp F.A., Becker C., Franchi L., Yoshihara E., Chen Z., Mullooly N., Mielke L.A., Harris J., Coll R.C., Mills K.H., Mok K.H., Newsholme P., Nunez G., Yodoi J., Kahn S.E., Lavelle E.C., O'Neill L.A. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat. Immunol. 2010, 11:897-904.
58. Duewell P., Kono H., Rayner K.J., Sirois C.M., Vladimer G., Bauernfeind F.G., Abela G.S., Franchi L., Nunez G., Schnurr M., Espevik T., Lien E., Fitzgerald K.A., Rock K.L., Moore K.J., Wright S.D., Hornung V., Latz E. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010, 464:1357-1361.
59. Eisenbarth S.C., Colegio O.R., O'Connor W., Sutterwala F.S., Flavell R.A. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008, 453:1122-1126.
60. Franchi L., Nunez G. The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity. Eur. J. Immunol. 2008, 38:2085-2089.
61. Li H., Willingham S.B., Ting J.P., Re F. Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J. Immunol. 2008, 181:17-21.
62. Kool M., Petrilli V., De Smedt T., Rolaz A., Hammad H., van Nimwegen M., Bergen I.M., Castillo R., Lambrecht B.N., Tschopp J. Cutting Edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J. Immunol. 2008, 181:3755-3759.
63. Henao-Mejia J., Elinav E., Jin C., Hao L., Mehal W.Z., Strowig T., Thaiss C.A., Kau A.L., Eisenbarth S.C., Jurczak M.J., Camporez J.P., Shulman G.I., Gordon J.I., Hoffman H.M., Flavell R.A. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012, 482:179-185.
64. Ayres J.S., Trinidad N.J., Vance R.E. Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota. Nat. Med. 2012, 18:799-806.
65. Franchi L., Kamada N., Nakamura Y., Burberry A., Kuffa P., Suzuki S., Shaw M.H., Kim Y.-G., Núñez G. NLRC4-driven production of IL-1β discriminates between pathogenic and commensal bacteria and promotes host intestinal defense. Nat. Immunol. 2012, 13:449-456.
66. Stienstra R., Joosten L.A., Koenen T., van Tits B., van Diepen J.A., van den Berg S.A., Rensen P.C., Voshol P.J., Fantuzzi G., Hijmans A., Kersten S., Muller M., van den Berg W.B., van Rooijen N., Wabitsch M., Kullberg B.J., van der Meer J.W., Kanneganti T., Tack C.J., Netea M.G. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell. Metab. 2010, 12:593-605.
67. Wen H., Gris D., Lei Y., Jha S., Zhang L., Huang M.T., Brickey W.J., Ting J.P. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 2011, 12:408-415.
68. Vandanmagsar B., Youm Y.H., Ravussin A., Galgani J.E., Stadler K., Mynatt R.L., Ravussin E., Stephens J.M., Dixit V.D. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 2011, 17:179-188.
69. Shaw M.H., Kamada N., Kim Y.-G., Núñez G. Microbiota-induced IL-1β, but not IL-6, is critical for the development of steady-state TH17 cells in the intestine. J. Exp. Med. 2012, 209:251-258.
70. Sutton C.E., Lalor S.J., Sweeney C.M., Brereton C.F., Lavelle E.C., Mills K.H.G. Interleukin-1 and IL-23 induce innate IL-17 production from γδ T cells, amplifying Th17 responses and autoimmunity. Immunity 2009, 31:331-341.
71. Lukens J.R., Barr M.J., Chaplin D.D., Chi H., Kanneganti T.-D. Inflammasome-derived IL-1β regulates the production of GM-CSF by CD4+ T cells and γδ T cells. J. Immunol. 2012, 188:3107-3115.
72. Huber S., Gagliani N., Zenewicz L.A., Huber F.J., Bosurgi L., Hu B., Hedl M., Zhang W., O'Connor W., Murphy A.J., Valenzuela D.M., Yancopoulos G.D., Booth C.J., Cho J.H., Ouyang W., Abraham C., Flavell R.A. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 2012, 491:259-263.
73. Dinarello C.A. Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. Am. J. Clin. Nutr. 2006, 83:447S-455S.
74. Murdoch S., Djuric U., Mazhar B., Seoud M., Khan R., Kuick R., Bagga R., Kircheisen R., Ao A., Ratti B., Hanash S., Rouleau G.A., Slim R. Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat. Genet. 2006, 38:300-302.
75. Slim R., Mehio A. The genetics of hydatidiform moles: new lights on an ancient disease. Clin. Genet. 2007, 71:25-34.
76. Milhavet F., Cuisset L., Hoffman H.M., Slim R., El-Shanti H., Aksentijevich I., Lesage S., Waterham H., Wise C., Sarrauste de Menthiere C., Touitou I. The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum. Mutat. 2008, 29:803-808.
77. Dixon P.H., Trongwongsa P., Abu-Hayyah S., Ng S.H., Akbar S.A., Khawaja N.P., Seckl M.J., Savage P.M., Fisher R.A. Mutations in NLRP7 are associated with diploid biparental hydatidiform moles, but not androgenetic complete moles. J. Med. Genet. 2012, 49:206-211.
78. Wang C.M., Dixon P.H., Decordova S., Hodges M.D., Sebire N.J., Ozalp S., Fallahian M., Sensi A., Ashrafi F., Repiska V., Zhao J., Xiang Y., Savage P.M., Seckl M.J., Fisher R.A. Identification of 13 novel NLRP7 mutations in 20 families with recurrent hydatidiform mole; missense mutations cluster in the leucine-rich region. J. Med. Genet. 2009, 46:569-575.
79. Williams D., Hodgetts V., Gupta J. Recurrent hydatidiform moles. Eur. J. Obstet. Gynecol. Reprod. Biol. 2010, 150:3-7.
80. Okada K., Hirota E., Mizutani Y., Fujioka T., Shuin T., Miki T., Nakamura Y., Katagiri T. Oncogenic role of NALP7 in testicular seminomas. Cancer Sci. 2004, 95:949-954.